Nonreplicating vectors in HIV vaccines

Por Johnson, JA, Barouch, DH, Baden, LR
Publicado em 2013

Humoral immune response profiling with peptide microarrays

Por Reimer U, Wenschuh H, Baden LR, Pau M, Weijtens M, Barouch DH
Publicado em 2012-09-01

Humoral immune response profiling with peptide microarrays

Por Reimer, U, Wenschuh, H, Baden, LR, Pau, M, Weijtens, M, Barouch, DH
Publicado em 2012

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

Por Walsh, SR, Seaman, MS, Johnson, JA, Tucker, RP, Krause, KH, Weijtens, M, Pau, MG, Goudsmit, J, Dolin, R, Barouch, DH, Baden, LR
Publicado em 2012

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Por Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, Choi, E, Tucker, R, Weitjens, M, Pau, MG, Goudsmit, J, Barouch, DH
Publicado em 2009